Treatment recommendations for patients with vitiligo during COVID-19.
作者信息
Rodrigues Michelle, Pandya Amit G, Hamzavi Iltefat, Ezzedine Khaled, Bekkenk Marcel W, Harris John E
机构信息
Chroma Dermatology, Pigment and Skin of Colour Centre, Wheelers Hill, Victoria, Australia.
Department of Dermatology, The Royal Children's Hospital, Parkville, Victoria, Australia.
出版信息
Australas J Dermatol. 2021 Aug;62(3):e481-e482. doi: 10.1111/ajd.13610. Epub 2021 May 24.
Abstract
摘要
相似文献
1
Treatment recommendations for patients with vitiligo during COVID-19.
Australas J Dermatol. 2021 Aug;62(3):e481-e482. doi: 10.1111/ajd.13610. Epub 2021 May 24.
2
A new-onset vitiligo following the inactivated COVID-19 vaccine.
J Cosmet Dermatol. 2022 Feb;21(2):429-430. doi: 10.1111/jocd.14677. Epub 2021 Dec 15.
3
Sudden onset of vitiligo after COVID-19 vaccine.
Dermatol Ther. 2022 Jan;35(1):e15196. doi: 10.1111/dth.15196. Epub 2021 Nov 15.
4
[Facial Vitiligo After SARS-CoV-2 Vaccination].
Actas Dermosifiliogr. 2022 Jul-Aug;113(7):721. doi: 10.1016/j.ad.2022.01.030. Epub 2022 Feb 19.
5
Lichen planus and vitiligo occurring after ChAdOx1 nCoV-19 vaccination against SARS-CoV-2.
Dermatol Ther. 2022 May;35(5):e15422. doi: 10.1111/dth.15422. Epub 2022 Mar 14.
6
Global recommendations for vitiligo management.
J Eur Acad Dermatol Venereol. 2023 Nov;37(11):2157-2158. doi: 10.1111/jdv.19490.
7
Association of home light therapy with patient-reported outcomes of vitiligo during the COVID-19 pandemic: An Internet-based survey.
Photodermatol Photoimmunol Photomed. 2021 Sep;37(5):425-427. doi: 10.1111/phpp.12675. Epub 2021 Mar 22.
8
Impact of treatment delays on vitiligo during the COVID-19 pandemic: A retrospective study.
Dermatol Ther. 2021 Jul;34(4):e15014. doi: 10.1111/dth.15014. Epub 2021 Jun 16.
9
Does autoimmune vitiligo protect against COVID-19 disease?
Exp Dermatol. 2021 Sep;30(9):1254-1257. doi: 10.1111/exd.14407. Epub 2021 Jun 17.
10
Views on vitiligo disease course and treatment among people living with vitiligo and healthcare providers worldwide.
Br J Dermatol. 2023 Oct 25;189(5):e94. doi: 10.1093/bjd/ljad350.
本文引用的文献
1
Recommendations for phototherapy during the COVID-19 pandemic.
J Am Acad Dermatol. 2020 Jul;83(1):287-288. doi: 10.1016/j.jaad.2020.04.091. Epub 2020 Apr 24.
2
COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australian/New Zealand consensus statement.
Australas J Dermatol. 2020 Aug;61(3):210-216. doi: 10.1111/ajd.13313. Epub 2020 May 3.
3
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease.
Lancet. 2020 Feb 15;395(10223):e30-e31. doi: 10.1016/S0140-6736(20)30304-4. Epub 2020 Feb 4.
4
Comparative safety of systemic immunomodulatory medications in adults with atopic dermatitis.
J Am Acad Dermatol. 2021 Aug;85(2):321-329. doi: 10.1016/j.jaad.2019.05.073. Epub 2019 May 31.
5
Infection Risk and Safety of Corticosteroid Use.
Rheum Dis Clin North Am. 2016 Feb;42(1):157-76, ix-x. doi: 10.1016/j.rdc.2015.08.004. Epub 2015 Oct 24.
Zotero 插件